Mesoblast Ltd
MESO- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001345099
No open-market purchases or sales by Mesoblast Ltd insiders were filed in the last 90 days; 72 institutions reported holding it in 13F filings for Q2 2026, worth $53.3M in total; no superinvestor holds it.
Other share classesMEOBF
Q3 2023 vs. Q2 2023
How the institutions holding Mesoblast Ltd changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 43 | 35 | −8 |
| Shares | 1.80M | 1.33M | −468.5K (−26.1%) |
| Value | $7.00M | $1.63M | −$5.37M (−76.7%) |
New holders (5)
Institutions that held Mesoblast Ltd at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Prosperity Wealth Management, Inc. | 64,150 | $78.9K | 0.05% |
| Virtu Financial LLC | 62,062 | $76.0K | 0.01% |
| Vident Advisory, LLC | 21,591 | $26.6K | 0.00% |
| Two Sigma Securities, LLC | 12,154 | $14.9K | 0.00% |
| Qube Research & Technologies Ltd | 8,231 | $10.1K | 0.00% |
Sold out (13)
Institutions that held Mesoblast Ltd at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Citadel Advisors LLC | 56,286 | $220.1K |
| Vident Investment Advisory, LLC | 36,413 | $142.4K |
| Delaney Dennis R | 24,000 | $93.8K |
| Belvedere Trading LLC | 18,053 | $70.6K |
| Evergreen Capital Management LLC | 16,012 | $62.6K |
| Cetera Advisor Networks LLC | 15,000 | $58.6K |
| Merit Financial Group, LLC | 13,406 | $52.4K |
| Creative Planning | 12,705 | $49.7K |
| JustInvest LLC | 12,538 | $49.0K |
| BNP Paribas Arbitrage, SA | 3,123 | $12.2K |
| UBS Group AG | 1,142 | $4.46K |
| Parallel Advisors, LLC | 190 | $743 |
| Ronald Blue Trust, Inc. | 15 | $0 |